Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
A pathway-guided kernel MLP architecture for interpretable cross-disease transfer from rheumatoid arthritis to hematological malignancies
Related
- Extracellular vesicles in the immune regulation of hematological malignancies: mechanisms, prognostic significance, and therapeutic opportunities
- Ginsenosides in hematopoietic homeostasis and hematological malignancies: context-dependent pharmacological effects and translational limitations
- The SKP2–Substrate Axis in Hematological Malignancies: Mechanisms of Oncogenesis and Opportunities for Targeted Therapy
- Integrated Immune Profiling Identifies Treatment-Associated Immune Patterns in Patients with B-Cell Hematological Malignancies.
- Histone lactylation in fibroblast-like synoviocytes drives CXCL1-mediated immune cell recruitment in rheumatoid arthritis
BibTeX
@article{temur2026pathwayguided,
title = {{A pathway-guided kernel MLP architecture for interpretable cross-disease transfer from rheumatoid arthritis to hematological malignancies}},
author = {Lütviye Özge Temur and Ebru Geçici Birkan and Esra İlbahar and Mehmet Gönen and Mehmet Güray Güler},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73848-2},
url = {https://www.nature.com/articles/s41598-026-73848-2},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - A pathway-guided kernel MLP architecture for interpretable cross-disease transfer from rheumatoid arthritis to hematological malignancies
AU - Lütviye Özge Temur
AU - Ebru Geçici Birkan
AU - Esra İlbahar
AU - Mehmet Gönen
AU - Mehmet Güray Güler
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-73848-2
UR - https://www.nature.com/articles/s41598-026-73848-2
SN - 2045-2322
ER -